This HTML5 document contains 107 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n10http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q57183295
rdf:type
wikibase:Item
schema:description
im Oktober 2018 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel наукова стаття, опублікована в жовтні 2018 article
p:P577
wds:Q57183295-AB232DDB-42A7-4220-89EA-E98E775998EF
wdt:P577
2018-10-06T00:00:00Z
p:P407
wds:Q57183295-564095C0-19D1-412F-9FBC-B19D0B00AA65
wdt:P407
wd:Q1860
p:P2860
wds:Q57183295-FD870B16-4D6D-49BE-94A3-646A6A65AA65 wds:Q57183295-EA5EA540-97ED-4116-B32D-A59E66196140 wds:Q57183295-E6E90E88-B339-4028-9EBE-8B0F1B1DE754 wds:Q57183295-DC9EBA95-FFB7-47C9-B72F-ADCA46183B8F wds:Q57183295-D2FB78E8-9808-4791-9864-086ECF933633 wds:Q57183295-BDA52D22-0823-494E-957C-C6914A0B6B8A wds:Q57183295-CAA547D4-547A-4092-B347-60FF852DF1E6 wds:Q57183295-A94ACFB5-D04F-419D-831A-A28B83F3286B wds:Q57183295-A57E39AA-0B4D-4D1C-B99A-0437DD52E944 wds:Q57183295-9E30B0EF-EF68-4A8D-A8E4-CA81F1C0B778 wds:Q57183295-A3D34986-0055-43AA-9D02-C4E1823BB3AD wds:Q57183295-A30E9411-81F9-4A02-AEF8-C01E694BC88B wds:Q57183295-8D559183-0EAF-4F53-BBDE-1FF1161386BC wds:Q57183295-8C428A24-506D-47F4-9076-E5EBDDD89718 wds:Q57183295-9DF9E72D-38B0-4B70-AB70-5D1C7253D6FF wds:Q57183295-751CC922-C3A3-453D-A5EE-6410393EB3D3 wds:Q57183295-6C76275C-BA1F-4617-BE28-E809B3293A76 wds:Q57183295-89BBD536-F34B-478B-8558-EE5115DB181D wds:Q57183295-60B9D0D0-2F55-4BC8-BCBE-AAF587867C20 wds:Q57183295-5DC742F9-E4D0-4419-B723-17590BDBDB6B wds:Q57183295-6C574224-B806-42A9-8CD4-3DCD6F8C3F68 wds:Q57183295-6A756B83-5244-48FB-BFED-F5C67332AAFC wds:Q57183295-22B179EB-C947-4328-8E10-E2CB4781BB26 wds:Q57183295-1C18C644-788F-4B4C-8091-72B469CACFBC wds:Q57183295-2D0CD87F-8174-41B0-BC85-F45383531977 wds:Q57183295-1853F103-5A35-411D-A1C6-660B67CD697D
wdt:P2860
wd:Q33493585 wd:Q40340899 wd:Q37899605 wd:Q68533479 wd:Q44265652 wd:Q27860904 wd:Q41992670 wd:Q47556294 wd:Q72528110 wd:Q46163335 wd:Q50040088 wd:Q40810672 wd:Q69342071 wd:Q46977887 wd:Q71261788 wd:Q54654989 wd:Q43885241 wd:Q46679425 wd:Q88427375 wd:Q37385672 wd:Q47642819 wd:Q40915962 wd:Q33408664 wd:Q37784388 wd:Q46677592 wd:Q38681576
p:P2093
wds:Q57183295-F38BB232-034E-42D7-82A2-8F2BF9A18C4F wds:Q57183295-BDA9E067-2B1F-4C57-A5CA-BF405BE4D39F wds:Q57183295-B549E522-6167-429D-AEC1-5747E98342E6 wds:Q57183295-3714DE17-269D-4C55-8D8C-0DEB5C00DF40 wds:Q57183295-5031FAC1-F1BD-46D9-A930-0A9914EA20AE wds:Q57183295-38F97544-8656-495E-BEC3-291D1D6196B1 wds:Q57183295-A8EFDC1F-473C-474F-800A-152B07AD45BE wds:Q57183295-A5BB05CA-0389-4F86-93C1-B9DB439C8DAA wds:Q57183295-AFA316F7-D9F5-443B-924F-9114296EA389
wdt:P2093
N Díaz S Del Barco I García Carbonero M Margelí M L Gonzálvez E Aguirre A Barnadas A Llombart S Servitja
rdfs:label
Real-world data on the efficacy and safety of weekly oral vinorelbine in breast cancer patients previously treated with anthracycline or taxane-based regimens Real-world data on the efficacy and safety of weekly oral vinorelbine in breast cancer patients previously treated with anthracycline or taxane-based regimens
skos:prefLabel
Real-world data on the efficacy and safety of weekly oral vinorelbine in breast cancer patients previously treated with anthracycline or taxane-based regimens Real-world data on the efficacy and safety of weekly oral vinorelbine in breast cancer patients previously treated with anthracycline or taxane-based regimens
schema:name
Real-world data on the efficacy and safety of weekly oral vinorelbine in breast cancer patients previously treated with anthracycline or taxane-based regimens Real-world data on the efficacy and safety of weekly oral vinorelbine in breast cancer patients previously treated with anthracycline or taxane-based regimens
p:P50
wds:Q57183295-EC8F0411-353C-45A9-A733-D091FEB4AA45 wds:Q57183295-B1BDEAA8-EF92-4240-8429-59BC9EAB9BEF
wdt:P50
wd:Q89412182 wd:Q57090126
p:P1476
wds:Q57183295-A1E708D0-EB0C-40E7-B1BC-CE65DDB44A8D
wdt:P1476
Real-world data on the efficacy and safety of weekly oral vinorelbine in breast cancer patients previously treated with anthracycline or taxane-based regimens
p:P304
wds:Q57183295-3C3AAF0E-918B-43CC-8041-C0E8B11A1A34
wdt:P304
459-466
p:P31
wds:Q57183295-822F4B73-1052-49C6-A693-C006A3BAFF34
wdt:P31
wd:Q13442814
p:P698
wds:Q57183295-E4E0C812-5373-4AE9-BCBE-FC41D56CFAC1
wdtn:P698
n12:30293232
wdt:P698
30293232
p:P1433
wds:Q57183295-EE220D58-E5B3-4A7D-A8B1-2932898E788F
wdt:P1433
wd:Q15754324
p:P433
wds:Q57183295-9764D2A7-C9C8-4C39-AD2E-0785ED2E9D0D
p:P478
wds:Q57183295-DD34C665-2A8E-4F8E-A13E-8967D66F0BBB
wdt:P433
4
wdt:P478
21
p:P356
wds:Q57183295-A669D71B-D245-429E-9557-6A7249404516
wdtn:P356
n10:S12094-018-1946-9
wdt:P356
10.1007/S12094-018-1946-9